| 000 | 01345 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515035227.0 | ||
| 264 | 0 | _c20060921 | |
| 008 | 200609s 0 0 hun d | ||
| 022 | _a0030-6002 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGéher, Pál | |
| 245 | 0 | 0 |
_a[The role of biologic agents in the therapy of ankylosing spondylitis]. _h[electronic resource] |
| 260 |
_bOrvosi hetilap _cJul 2006 |
||
| 300 |
_a1203-13 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Meta-Analysis; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHungary |
| 650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aSpondylitis, Ankylosing _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aNagy, Marianna Bettina | |
| 700 | 1 | _aPéntek, Márta | |
| 700 | 1 | _aTóth, Edit | |
| 700 | 1 | _aBrodszky, Valentin | |
| 700 | 1 | _aGulácsi, László | |
| 773 | 0 |
_tOrvosi hetilap _gvol. 147 _gno. 26 _gp. 1203-13 |
|
| 999 |
_c16485915 _d16485915 |
||